MSF-USA: 2004 Activity Report


International Activity Report 2004 Uzbekistan International staff: 132 National Staff: 12

Moving forward on TB treatment MSF is now focusing on the particularly difficult issue of providing care for people with multidrug- resistant tuberculosis (TB). A survey found that the Karakalpakstan area has the highest incidence of resistant TB in the Aral Sea region. MSF is now treating 100 patients there in an intensive DOTS–Plus (Directly Observed Treatment, Short-course) treatment program. This program builds on the regimen already in place and adds second-line drugs to overpower the resistant bacilli. Currently, MSF is exploring the potential of expanding the program to treat all patients with resistance in two pilot regions. MSF has worked in Uzbekistan since 1997.

Table of
Contents

The Year in Review

Rowan Gilles, M.D., President, MSF International Council

Marine Buissonnière, MSF Secretary-General

In Memoriam

June 2, 2004
Afghanistan's Badghis Province

Military humanitarianism:
A deadly confusion

By Fabrice Weissman Research Director,
MSF-Foundation, Paris

The struggle to reach people in need

By Kenny Gluck
MSF Director of Operations, Amsterdam

No cash, no care
MSF’s confrontation with cost recovery

By Mit Philips
M.D., MscPH., Analyst
Access to Health Care Research Unit, Brussels

MSF and HIV/AIDS: Expanding treatment, facing new challenges

By Alexandra Calmy, M.D., Advisor to MSF's Campaign for Access to Essential Medicines

Running out of breath? Tuberculosis control in the 21st century

By Sally Hargreaves and Laura Hakokongas for the MSF Campaign for Access to Essential Medicines The Americas

Helping immigrants at Europe's door

By Carlos Ugarte
Head of Mission for MSF's projects in Spain

	contact us \| donate \| other MSF world offices \| link to us \| copyright statement \| privacy policy This site is maintained by the U.S. section of Doctors Without Borders/Médecins Sans Frontières (MSF) ©2006 MSF All rights reserved.